1. Home
  2. Stocks
  3. Star Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Strides Pharma Science Share Price Strides Pharma Science

    Mid Cap
    ₹876.7
    -6.75 (-0.76%)
    • Advice
    • Hold
    28 April, 2024 08:51 BSE: 532531 NSE: STARISIN: INE939A01011

    Start SIP in Strides Pharma Science

    Start SIP

    Strides Pharma Science Performance

    Day Range

    • Low 866
    • High 900
    ₹ 876

    52 Week Range

    • Low 330
    • High 902
    ₹ 876
    • Open Price884
    • Previous Close883
    • Volume150685

    Strides Pharma Science Share Price

    • Over 1 Month +13.48%
    • Over 3 Month +27.74%
    • Over 6 Month +84.34%
    • Over 1 Year +157.13%

    Strides Pharma Science Key Statistics

    P/E Ratio -81.9
    PEG Ratio -2
    Market Cap Cr 8,057
    Price to Book Ratio 3.7
    EPS 2.3
    Dividend 0.2
    Relative Strength Index 65.21
    Money Flow Index 71.43
    MACD Signal 19.52
    Average True Range 31.2
    Strides Pharma Science Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 520540475564
    Operating Expenses Qtr Cr 454497420444
    Operating Profit Qtr Cr 664356119
    Depreciation Qtr Cr 21212123
    Interest Qtr Cr 44403743
    Tax Qtr Cr 1313
    Net Profit Qtr Cr 31862
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,939
    Operating Expenses Annual Cr 1,756
    Operating Profit Annual in Cr 98
    Depreciation Cr 94
    Interest Annual Cr 139
    Tax Annual Cr -69
    Net Profit Annual Cr 5
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 242
    Cash from Investing Activity Annual Cr -183
    Cash from Financing Annual Activity Cr 11
    Net Cash Flow Annual Cr 70
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 3,455
    Fixed Assets Annual Cr 652
    Total Non Current Assets Annual Cr 3,493
    Total Current Assets Annual Cr 2,126
    Total Assets Annual Cr 5,620
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 383
    ROE Annual % 0
    ROCE Annual % 2
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 10
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 1,038999930986
    Operating Expenses Qtr Cr 844846763831
    Operating Profit Qtr Cr 194153167156
    Depreciation Qtr Cr 51606061
    Interest Qtr Cr 79797681
    Tax Qtr Cr 10-7107
    Net Profit Qtr Cr 50-131-7-10
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 3,779
    Operating Expenses Annual Cr 3,258
    Operating Profit Annual in Cr 430
    Depreciation Cr 243
    Interest Annual Cr 261
    Tax Annual Cr -55
    Net Profit Annual Cr -203
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 44
    Cash from Investing Activity Annual Cr 302
    Cash from Financing Annual Activity Cr -214
    Net Cash Flow Annual Cr 133
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 2,195
    Fixed Assets Annual Cr 1,948
    Total Non Current Assets Annual Cr 3,395
    Total Current Assets Annual Cr 3,243
    Total Assets Annual Cr 6,638
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 239
    ROE Annual % -9
    ROCE Annual % 8
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 14
    Sign Up to Know More
    Invest in Strides Pharma Science

    Strides Pharma Science Technicals

    EMA & SMA

    Current Price
    ₹876.7
    -6.75 (-0.76%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹843.68
    • 50 Day
    • ₹801.81
    • 100 Day
    • ₹734.17
    • 200 Day
    • ₹635.29
    • 20 Day
    • ₹840.10
    • 50 Day
    • ₹813.30
    • 100 Day
    • ₹728.06
    • 200 Day
    • ₹599.21

    Strides Pharma Science Resistance and Support

    PIVOT
    ₹881.
    Resistance
    First Resistance 895.70
    Second Resistance 914.70
    Third Resistance 929.40
    RSI 65.21
    MFI 71.43
    MACD Single Line 19.52
    MACD 22.85
    Support
    First Resistance 862.00
    Second Resistance 847.30
    Third Resistance 828.30

    Strides Pharma Science Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 169,106 6,776,077 40.07
    Week 350,432 14,613,014 41.7
    1 Month 332,965 17,763,680 53.35
    6 Month 759,035 33,086,324 43.59

    Strides Pharma Science Result Highlights

    Strides Pharma Science Synopsis

    NSE-Medical-Generic Drugs

    Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1854.50 Cr. and Equity Capital is Rs. 90.30 Cr. for the Year ended 31/03/2023. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
    Market Cap 8,057
    Sales 2,099
    Shares in Float 6.80
    No of funds 162
    Yield 0.17
    Book Value 2.29
    U/D Vol ratio 2.6
    LTDebt / Equity 8
    Alpha 0.26
    Beta 1.18

    Strides Pharma Science

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 25.88%27.39%27.78%28.07%
    Mutual Funds 10.57%13.09%13.67%13.86%
    Insurance Companies 5.77%4.46%4.54%4.54%
    Foreign Portfolio Investors 24.57%19.45%17.25%16.72%
    Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
    Individual Investors 21.19%22.64%23.39%24.93%
    Others 12.01%12.96%13.36%11.87%

    Strides Pharma Science Management

    Name Designation
    Mr. Arun Kumar Exe.Chairman & Mng.Director
    Mr. Badree Komandur Executive Director & Group CFO
    Dr. Kausalya Santhanam Independent Director
    Mr. Bharat D Shah Independent Director
    Mr. Homi Rustam Khusrokhan Independent Director
    Mr. S Sridhar Independent Director

    Strides Pharma Science Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Strides Pharma Science Corporate Action

    Date Purpose Remarks
    2024-01-30 Quarterly Results
    2023-10-30 Quarterly Results
    2023-09-25 Scheme of Arrangement
    2023-08-02 Quarterly Results
    2023-05-25 Audited Results & Final Dividend
    Date Purpose Remarks
    2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
    2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend

    Strides Pharma Science MF Shareholding

    Name Amount(cr)
    SBI Long Term Equity Fund Regular Payout of Income Distribution cum capital wdrl 21,976
    Aditya Birla Sun Life Flexi Cap Fund Growth 19,967
    Quant Small Cap Fund Growth 17,349
    Quant Active Fund Growth 8,732
    Aditya Birla Sun Life Pure Value Fund Growth 5,684

    Strides Pharma Science FAQs

    What is Share Price of Strides Pharma Science ?

    Strides Pharma Science share price is ₹876 As on 28 April, 2024 | 08:37

    What is the Market Cap of Strides Pharma Science ?

    The Market Cap of Strides Pharma Science is ₹8056.8 Cr As on 28 April, 2024 | 08:37

    What is the P/E ratio of Strides Pharma Science ?

    The P/E ratio of Strides Pharma Science is -81.9 As on 28 April, 2024 | 08:37

    What is the PB ratio of Strides Pharma Science ?

    The PB ratio of Strides Pharma Science is 3.7 As on 28 April, 2024 | 08:37

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.